| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 04/04/2001 | CN1290299A Process for preparing human proinsulin |
| 04/04/2001 | CN1290161A Nuclear receptor ligands and ligand binding domains |
| 04/04/2001 | CN1064051C Calcitonin-like material of solmon and eel without dithio-bond and preparation method |
| 04/04/2001 | CN1064050C Biologic antibiotic peptide, and method for preparing same |
| 04/04/2001 | CN1064049C Thrombopoietin and its producing process |
| 04/03/2001 | US6210941 Methods for the detection and isolation of proteins |
| 04/03/2001 | US6210903 Amino acid sequence which is optionally modified and biotinylated |
| 04/03/2001 | US6210901 Modified hepatitis c virus amino acid sequence which binds to an antibody; for screening blood samples |
| 04/03/2001 | US6210894 Method and apparatus for conducting an array of chemical reactions on a support surface |
| 04/03/2001 | US6210685 Acellular whooping cough vaccines. |
| 04/03/2001 | CA2183371C Pna combinatorial libraries and improved methods of synthesis |
| 03/29/2001 | WO2001022078A1 Method and device for detecting and isolating pharmacological compounds being contained in substance mixtures |
| 03/29/2001 | WO2001021646A1 Protein structures and protein fibres |
| 03/28/2001 | EP1087013A2 Immunoglobulins devoid of light chains |
| 03/28/2001 | EP1087011A2 Methods for preventing degradation of protein c |
| 03/28/2001 | EP1086742A1 Combinatorial strategies for polymer synthesis |
| 03/28/2001 | EP1086121A1 Non-enzymatic chemical amidation process |
| 03/28/2001 | EP1086120A1 Method for preparing virus-safe pharmaceutical compositions |
| 03/28/2001 | EP1086119A1 Purification of antibodies |
| 03/28/2001 | EP1086065A4 Combinatorial synthesis of multibinding libraries |
| 03/28/2001 | EP1086065A1 Combinatorial synthesis of multibinding libraries |
| 03/28/2001 | EP1085903A1 Egg surface proteins and methods for use for modulating fertility |
| 03/28/2001 | EP1085894A1 Beta 3-adrenergic receptor agonists |
| 03/28/2001 | EP1085889A2 Novel therapeutic agents that modulate endothelin receptors |
| 03/28/2001 | EP1085887A2 Novel angiotensin receptor modulators and their uses |
| 03/28/2001 | EP1085870A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 03/28/2001 | EP1085868A1 H1-histamine receptor antagonists |
| 03/28/2001 | EP1085847A2 Novel therapeutic agents that modulate estrogen receptors |
| 03/28/2001 | EP0943131B1 Method, system and program for synthesis-based simulation of chemicals having biological functions |
| 03/28/2001 | EP0767800B1 Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase |
| 03/28/2001 | EP0495096B1 Plant fatty acid synthases |
| 03/28/2001 | CN1063796C Preparation method for drythropoietin isoforms |
| 03/28/2001 | CN1063795C Method for production of glucagon |
| 03/28/2001 | CN1063744C 15-deoxyspergulin analogs, their method of preparation and their use in therapeutics |
| 03/27/2001 | US6208942 Molecular hologram QSAR |
| 03/27/2001 | US6207807 Immobilizing a peptide which binds to fc region of antibody onto an affinity chromatography support, packing into column, equilibrating with buffer, applying solution to column, washing with eluent to remove impurites, eluting antibodies |
| 03/27/2001 | US6207806 IGF-I purification process |
| 03/27/2001 | US6207802 Non-human, mammalian polypeptide of defined amino acid sequence which activates the growth of early hematopoietic progenitor cells; treatment of blood disorders; anticarcinogenic agents; bone marrow regeneration |
| 03/27/2001 | US6207446 Selection of proteins using RNA-protein fusions |
| 03/27/2001 | US6207417 DNA encoding stem cell factor |
| 03/27/2001 | CA2166297C Process for manufacture of 1-deamino-8-d-arginine vasopressin |
| 03/27/2001 | CA2081450C Biologically active peptides containing d-2-alkyltrypthophan |
| 03/22/2001 | WO2001020331A1 Substrates and screening methods for transport proteins |
| 03/22/2001 | WO2001019852A2 Methods of peptide preparation |
| 03/22/2001 | WO2001019849A1 A process for the preparation of h-tyr-d-ala-phe(f)-phe-nh¿2? |
| 03/22/2001 | WO2001019846A1 Transgenically produced fusion proteins |
| 03/22/2001 | WO2001019484A1 Purification device and purification method |
| 03/22/2001 | WO2001019483A1 Device through which particles can pass, for separating substances using porous, flat adsorption membranes |
| 03/22/2001 | WO2001002332A3 Process for the preparation of 3,3-dimethylbutanal |
| 03/22/2001 | WO2000059943A3 MONOCLONAL ANTIBODIES AGAINST HUMAN PROTEIN Mcm3, PROCESS FOR THEIR PRODUCTION, AND THEIR USE |
| 03/22/2001 | WO2000052037A8 Echinocandin/carbohydrate complexes |
| 03/22/2001 | WO2000013019A9 Receptor for underivatized, aqueous soluble beta-(1,3)-glucan |
| 03/22/2001 | WO1999063936A8 Novel therapeutic agents that modulate endothelin receptors |
| 03/22/2001 | CA2388747A1 Purification device and purification method |
| 03/22/2001 | CA2383184A1 A process for the preparation of h-tyr-d-ala-phe(f)-phe-nh2 |
| 03/22/2001 | CA2382725A1 Transgenically produced fusion proteins |
| 03/22/2001 | CA2382544A1 Methods of peptide preparation |
| 03/21/2001 | EP1085000A1 Process for producing carboxylic acid derivative and condensing agent comprising quaternary ammonium salt |
| 03/21/2001 | EP1084454A1 Free-form nanofabrication using multi-photon excitation |
| 03/21/2001 | EP1084147A1 Process for producing immunoglobulins for intravenous administration and other immunoglobulin products |
| 03/21/2001 | EP1084136A1 Separation of protein monomers from aggregates by use of ion-exchange chromatography |
| 03/21/2001 | EP1083980A2 Modulation of molecular interaction sites on rna and other biomolecules |
| 03/21/2001 | EP1083921A1 Novel leukotriene receptor antagonists and their uses |
| 03/21/2001 | EP1083917A1 Novel analgesic agents |
| 03/21/2001 | EP1083893A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d 1? receptors |
| 03/21/2001 | EP1083888A1 MULTIBINDING AGENTS THAT MODULATE PPARgamma AND RXR RECEPTORS |
| 03/21/2001 | EP0714402B9 Polymer modification |
| 03/20/2001 | US6205404 DNA-binding proteins of the zinc-finger class |
| 03/20/2001 | US6204393 In aqueous solution; controlling ph; neutralization |
| 03/20/2001 | US6204385 Reacting the corresponding nitrile with ammonia, amine or hydrazine in the presence of a mercaptocarboxylic acid |
| 03/20/2001 | US6204367 Elisa kit for quantification of C-terminal telopeptides of type I collagen in human serum |
| 03/20/2001 | US6204362 Method of purifying whey of lactic acid fermentation by electrodialysis |
| 03/20/2001 | US6204361 Method of peptide synthesis |
| 03/20/2001 | US6204326 Adding peptide nucleic acid units to an amine terminated peptide nucleic acid oligomer on a solid phase synthetic resin; biosynthesis |
| 03/20/2001 | US6204247 Reacting a leptin with 0.5-5 fold molar excess of edta dianhydride to to form a monomer or dimer |
| 03/20/2001 | US6203775 Conjugating metallically labelled compound to protein; reacting with polypeptide sulfhydryl group; medical diagnosis; cytolysis |
| 03/20/2001 | CA1341207C Analogues of insulin-like growth factor-1 |
| 03/20/2001 | CA1341206C Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them |
| 03/15/2001 | WO2001018627A2 Method and apparatus for computer automated detection of protein and nucleic acid targets of a chemical compound |
| 03/15/2001 | WO2001018234A1 Method to identify gene function using small molecule probes |
| 03/15/2001 | WO2001018059A2 Congener independent detection of microcystin and nodularin congeners |
| 03/15/2001 | WO2001018036A2 Methods and reagents for regulating gene expression |
| 03/15/2001 | WO2000066761A3 Method of removing n-terminal alanine residues from polypeptides with aeromonas aminopeptidase |
| 03/15/2001 | CA2383186A1 Method to identify gene function using small molecule probes |
| 03/14/2001 | EP1082344A2 Glycoproteins having lipid mobilising properties and therapeutic applications thereof |
| 03/14/2001 | EP1082339A2 Rationally designed peptides, production and use thereof |
| 03/14/2001 | EP1082289A1 Methods for identifying novel multimeric agents that modulate receptors |
| 03/14/2001 | EP1082126A1 Novel peptides |
| 03/14/2001 | EP0710245B1 Linear substituted oligoalkyleneimine libraries |
| 03/14/2001 | CN1287689A Affinity based self-assembly systems and devices for photonic and electronic applications |
| 03/14/2001 | CN1287167A Technological process of extracting nutritious acetasa SOD |
| 03/14/2001 | CN1287125A Method of extracting immune globulin A from milk |
| 03/13/2001 | US6201110 Mixture of protease conjugated to polymer with molecular weight from 1 to 60 kilodaltons and another substance which makes it unsuitable for pharmaceutical use; cosmetics; dentrifices; detergents; hair spray; shampoo; agrochemicals |
| 03/13/2001 | US6201103 Peptide nucleic acid incorporating a chiral backbone |
| 03/13/2001 | US6200782 Fusion proteins linked to nucleotide sequences; for the preferential adjustment of nucleotide sequences |
| 03/13/2001 | US6200768 Detecting compounds efficient in the dissolution of an alzheimer's protein; incubate preferential protein with kinase, monitor helix formation, incubate with modulator and detect blocking action by modulator |
| 03/13/2001 | CA1341204C Analogues of igf-1 and igf-2 |
| 03/08/2001 | WO2001016862A2 Methods and compositions utilizing a branch and terminate algorithm for protein design |
| 03/08/2001 | WO2001016810A2 A computer-based method for macromolecular engineering and design |
| 03/08/2001 | WO2001016352A1 Methods for encoding and sorting in vitro translated proteins |